PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34726488-7	2021	blaKPC-2 plasmid curing in 28 strains restored CAZ-AVI susceptibility, suggesting that blaKPC-2 was the mediator of CAZ-AVI resistance.	avibactam, ceftazidime drug combination	47-54	blaKPC	Pseudomonas aeruginosa	0-6	
34726488-7	2021	blaKPC-2 plasmid curing in 28 strains restored CAZ-AVI susceptibility, suggesting that blaKPC-2 was the mediator of CAZ-AVI resistance.	avibactam, ceftazidime drug combination	116-123	blaKPC	Pseudomonas aeruginosa	0-6	
34726488-15	2021	The observed correlation between the blaKPC copy number and CAZ-AVI resistance suggests that close monitoring of the susceptibility of the strain during treatment is required.	avibactam, ceftazidime drug combination	60-67	blaKPC	Pseudomonas aeruginosa	37-43	
35019766-6	2022	The CRPA strain PA2207 is a carbapenem- and CZA-resistant strain that harbors a mutated blaKPC gene, named blaKPC-90.	avibactam, ceftazidime drug combination	44-47	blaKPC	Pseudomonas aeruginosa	88-94	
35019766-17	2022	Our study further emphasized that CZA resistance caused by blaKPC gene mutation could be selected in CRPA after CZA therapy.	avibactam, ceftazidime drug combination	34-37	blaKPC	Pseudomonas aeruginosa	59-65	
35019766-17	2022	Our study further emphasized that CZA resistance caused by blaKPC gene mutation could be selected in CRPA after CZA therapy.	avibactam, ceftazidime drug combination	112-115	blaKPC	Pseudomonas aeruginosa	59-65